发现一种变革性的癌症药物:ibrutinib的案例
Liam Bendicksen1, Lawrence King2, Edward R Scheffer Cliff3
1Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Yale Law School, New Haven, CT, USA.
Drug discovery today
|November 20, 2025
概括
科学家们探索了IBRUTINIB的发现,它是一种变革性的癌症药物. 它的旅程涉及从自身免疫研究重新利用和克服发展障碍,突出药物创新途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 变革性药物显著改善了患者的治疗结果.
- 关于转型药物的发现和开发的定性研究仍然有限.
- 了解药物开发的细微旅程对于未来的创新至关重要.
研究的目的:
- 定性地调查ibrutinib (Imbruvica) 的发现和开发过程.
- 探索科学和商业转型,导致ibrutinib作为癌症治疗的重新定位.
- 确定在ibrutinib开发过程中遇到的挑战,特别是与其新的作用机制相关的挑战.
主要方法:
- 进行了半结构化采访,与参与ibrutinib发现的科学家进行了采访.
- 分析了ibrutinib从工具化合物到治疗剂的历史轨迹.
- 检查了现有反应标准对具有新机制的药物的开发的影响.
主要成果:
- 易布鲁替尼最初被开发为一种工具化合物,用于自身免疫性疾病研究.
- 一家生物技术公司收购并重新定位了ibrutinib用于癌症治疗,特别是慢性淋巴细胞白血病.
- 由于响应标准不适应ibrutinib独特的作用机制,开发面临挑战.
结论:
- 开发像ibrutinib这样的变革性药物需要复杂的科学和商业重新定位.
- 克服不符合新药机制的监管和科学标准对于患者获取至关重要.
- 本案例研究提供了对药物发现和开发的巧合和挑战性质的见解.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936


